ecabet has been researched along with Colitis Gravis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lawrance, IC | 1 |
Adachi, S; Handa, O; Ichikawa, H; Kokura, S; Mizushima, K; Naito, Y; Okuda, T; Takagi, T; Uchiyama, K; Yoshikawa, T | 1 |
Furuta, R; Goto, H; Kusugami, K | 1 |
Inui, T; Kimura, I; Nagasaki, M; Noto, T; Okuyama, K; Watanable, A; Yamada, H | 1 |
Horie, Y; Iizuka, M; Itou, H; Konno, S; Shindo, K; Shirasaka, T; Watanabe, S | 1 |
Masuda, J; Mitsuyama, K; Sata, M; Tomiyasu, N; Tsuruta, O; Yamasaki, H | 1 |
Caprioli, F; Monteleone, G | 1 |
Kasai, S; Kohgo, Y; Kono, T; Nomura, M | 1 |
2 review(s) available for ecabet and Colitis Gravis
Article | Year |
---|---|
[Enema therapy for ulcerative colitis patients].
Topics: Abietanes; Alanine; Anesthetics, Local; Betamethasone; Colitis, Ulcerative; Enema; Fatty Acids, Volatile; Humans; Mesalamine; Quinolones; Severity of Illness Index; Sucralfate | 2005 |
Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
Topics: Abietanes; Administration, Rectal; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Colitis, Ulcerative; Enema; Humans; Treatment Outcome | 2007 |
2 trial(s) available for ecabet and Colitis Gravis
Article | Year |
---|---|
High affinity of ecabet sodium for inflamed colonic mucosa in ulcerative colitis.
Topics: Abietanes; Adult; Anti-Ulcer Agents; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male | 2007 |
Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
Topics: Abietanes; Adult; Aged; Anti-Ulcer Agents; Colitis, Ulcerative; Colonoscopy; Diterpenes; Enema; Female; Humans; Male; Middle Aged; Proctocolitis; Remission Induction | 2001 |
4 other study(ies) available for ecabet and Colitis Gravis
Article | Year |
---|---|
Ecabet sodium: a potential new agent in the management of distal colitis.
Topics: Abietanes; Acute Disease; Animals; Anti-Ulcer Agents; Cell Movement; Colitis, Ulcerative; Colon; Extracellular Signal-Regulated MAP Kinases; Humans; Intestinal Mucosa; Phosphorylation; Rats; Wound Healing | 2010 |
Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
Topics: Abietanes; Acute Disease; Administration, Rectal; Animals; Anti-Ulcer Agents; Cell Line; Cell Movement; Colitis, Ulcerative; Colon; Disease Models, Animal; Enema; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Intestinal Mucosa; Male; Phosphorylation; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid; Wound Healing | 2010 |
Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.
Topics: Abietanes; Administration, Rectal; Animals; Anti-Ulcer Agents; Cell Culture Techniques; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Enema; Enterocytes; Humans; Male; Neutrophils; Rats; Rats, Sprague-Dawley | 2005 |
Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
Topics: Abietanes; Adult; Anti-Ulcer Agents; Colitis, Ulcerative; Drug Resistance; Enema; Female; Humans; Male; Middle Aged; Steroids; Treatment Outcome | 2006 |